tradingkey.logo
tradingkey.logo
Search

ACADIA Pharmaceuticals Inc

ACAD
Add to Watchlist
25.110USD
-1.300-4.92%
Market hours 09/23, 14:33ET
4.30BMarket Cap
11.26P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-4.92%

5 Days

-6.17%

1 Month

-14.88%

6 Months

+21.07%

Year to Date

-5.99%

1 Year

+2.36%

Key Figures

26.365Open
26.855High
56.10KVolume
11.26P/E TTM
25.66P/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
26.410Prev. Close
24.970Low
1.42MTurnover
18.99P/E Static
3.29P/B
0.00%Div Yield TTM
27.44%ROA
30.96052wk High
0.03Volume Ratio
226.45MNet Profit
171.24MShares
2.2300EPS TTM
0.84Beta
37.32%ROE
19.69052wk Low
7.14%Amplitude
90.78%Gross Margin
4.30BMarket Cap
5.69Reward/Risk
2.37%Risk Rate
More news coming soon, stay tuned...

ACADIA Pharmaceuticals Inc's Score

-0.02vs previous score
Forecast7.90
Financial Health9.35
Technical3.39
Valuation Dimensions7.87
Institutional Confidence10.00
Risk Assessment7.60

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
33.889Target Price
+24.18%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy55555543
Buy1011111111111110
Hold44444456
Sell11111111
Strong Sell00000000

ACADIA Pharmaceuticals Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.18/0.06
Revenue / Forecast
307.96M/295.86M

ACADIA Pharmaceuticals Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolACAD
Number of employees653
CountryUnited States of America

Ownership

ShareholdersProportion
Baker Bros. Advisors LP25.05%
BlackRock Institutional Trust Company, N.A.10.77%
Vanguard Portfolio Management, LLC5.06%
State Street Investment Management (US)4.62%
Shareholder TypesProportion
Hedge Fund35.20%
Investment Advisor32.87%
Investment Advisor/Hedge Fund25.77%
Research Firm1.93%

FAQs

What is the current price of ACADIA Pharmaceuticals Inc (ACAD)?

The current price of ACADIA Pharmaceuticals Inc (ACAD) is 26.41.

What is the symbol of ACADIA Pharmaceuticals Inc?

The ticker symbol of ACADIA Pharmaceuticals Inc is ACAD.

What is the 52-week high of ACADIA Pharmaceuticals Inc?

The 52-week high of ACADIA Pharmaceuticals Inc is 30.96.

What is the 52-week low of ACADIA Pharmaceuticals Inc?

The 52-week low of ACADIA Pharmaceuticals Inc is 19.69.

What is the market capitalization of ACADIA Pharmaceuticals Inc?

The market capitalization of ACADIA Pharmaceuticals Inc is 4.52B.

Is ACADIA Pharmaceuticals Inc (ACAD) currently rated as Buy, Hold, or Sell?

According to analysts, ACADIA Pharmaceuticals Inc (ACAD) has an overall rating of Buy, with a price target of 33.89.

What is the Earnings Per Share (EPS TTM) of ACADIA Pharmaceuticals Inc (ACAD)?

The Earnings Per Share (EPS TTM) of ACADIA Pharmaceuticals Inc (ACAD) is 2.23.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.